Unknown

Dataset Information

0

A Novel Nanosystem Realizing Curcumin Delivery Based on Fe3O4@Carbon Dots Nanocomposite for Alzheimer's Disease Therapy.


ABSTRACT: Alzheimer's disease (AD) is the most common neurodegenerative disease, which seriously affects human health but lacks effective treatment methods. Amyloid ? (A?) aggregates are considered a possible target for AD treatment. Evidence is increasingly showing that curcumin (CUR) can partly protect cells from A?-mediated neurotoxicity by inhibiting A? aggregation. However, the efficiency of targeted cellular uptake and bioavailability of CUR is very low due to its poor stability and water-solubility. In order to better improve the cell uptake efficiency and bioavailability of CUR and reduce the cytotoxicity of high-dose CUR, a novel CUR delivery system for AD therapy has been constructed based on the employment of the Fe3O4@carbon dots nanocomposite (Fe3O4@CDs) as the carrier. CUR-Fe3O4@CDs have a strong affinity toward A? and effectively inhibit extracellular A? fibrillation. In addition, CUR-Fe3O4@CDs can inhibit the production of reactive oxygen species (ROS) mediated by A? fibrils and the corresponding neurotoxicity in PC12 cells. More importantly, it can restore nerve damage and maintained neuronal morphology. These results indicate that the application of CUR-Fe3O4@CDs provides a promising platform for the treatment of AD.

SUBMITTER: Kuang Y 

PROVIDER: S-EPMC7744485 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

A Novel Nanosystem Realizing Curcumin Delivery Based on Fe<sub>3</sub>O<sub>4</sub>@Carbon Dots Nanocomposite for Alzheimer's Disease Therapy.

Kuang Ying Y   Zhang Jingwen J   Xiong Mogao M   Zeng Weijia W   Lin Xiaofeng X   Yi Xiaoqing X   Luo Yan Y   Yang Min M   Li Feng F   Huang Qitong Q  

Frontiers in bioengineering and biotechnology 20201203


Alzheimer's disease (AD) is the most common neurodegenerative disease, which seriously affects human health but lacks effective treatment methods. Amyloid β (Aβ) aggregates are considered a possible target for AD treatment. Evidence is increasingly showing that curcumin (CUR) can partly protect cells from Aβ-mediated neurotoxicity by inhibiting Aβ aggregation. However, the efficiency of targeted cellular uptake and bioavailability of CUR is very low due to its poor stability and water-solubility  ...[more]

Similar Datasets

| S-EPMC6776962 | biostudies-literature
| S-EPMC5438339 | biostudies-literature
| S-EPMC7393085 | biostudies-literature
| S-EPMC9041725 | biostudies-literature
| S-EPMC6749273 | biostudies-literature
| S-EPMC7358215 | biostudies-literature
| S-EPMC9865864 | biostudies-literature
| S-EPMC6794625 | biostudies-literature
| S-EPMC8640100 | biostudies-literature
| S-EPMC7599867 | biostudies-literature